Abbott Laboratories (NYSE:ABT) kept active in technical ratio analysis, on current situation shares price inched down -0.31% to $71.82. The total volume of 6.13 Million shares held in the session, while on average its shares change hands 5121.25 shares.
Efficiency Evaluation in Focus
Entering into profitability analysis, the co has noticeable returns on equity ratio of 3.00%, which discloses how corporation’s management efficiently generates profit from shareholders invested money. The returns on investment very popular metric among passive investors, it stands at 2.20%, when it lies in positive figure than security is feasible for investment or goes for higher ROI stocks. To see the other side of picture, profit margin of Abbott Laboratories (NYSE:ABT) stands at positive 3.10%; that indicates a firm actually every dollar of sales keeps in earnings. The 1.30% returns on assets present notable condition of firm. Mostly ROA known as a comparative measure, it is best to compare it against a firm’s previous ROA numbers or the ROA of a same firm.
Following previous ticker characteristics, Abbott Laboratories (NYSE:ABT) also run on active notice, stock price inched down -0.31% after traded at $71.82 in most recent trading session.
ABT has price to earnings ratio of 54.95 and the price to current year EPS stands at 44.60%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 11.98%. The earning yield also gives right direction to lure investment, as the co has 1.56% dividend yield. Moving toward ratio analysis, it has current ratio of 1.60 and quick ratio was calculated as 1.20. The debt to equity ratio appeared as 0.68 for seeing its liquidity position.
To find out the technical position of ABT, Abbott Laboratories (NYSE:ABT) holds price to book ratio of 4.13 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. It has forward price to earnings ratio of 22.21. The price to earnings growth ratio calculated as 4.64. ABT is presenting price to cash flow of 38.46 and free cash flow concluded as 43.22.
Taking notice on volatility measures, price volatility of stock was 1.34% for a week and 1.19% for a month. The price volatility’s Average True Range for 14 days was 0.94. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 1.80 out of 1-5 scale with week’s performance of -1.64%. Abbott Laboratories (NYSE:ABT) ‘s institutional ownership was registered as 74.60%, while insider ownership was 0.70%.